212 related articles for article (PubMed ID: 24794160)
1. Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy.
Jayalakshmi S; Vooturi S; Bana AK; Sailaja S; Somayajula S; Mohandas S
Seizure; 2014 Aug; 23(7):527-32. PubMed ID: 24794160
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
Fernando-Dongas MC; Radtke RA; VanLandingham KE; Husain AM
Seizure; 2000 Sep; 9(6):385-8. PubMed ID: 10985993
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
5. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
Calleja S; Salas-Puig J; Ribacoba R; Lahoz CH
Seizure; 2001 Sep; 10(6):424-7. PubMed ID: 11700996
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate.
de Araujo Filho GM; Pascalicchio TF; Lin K; Sousa PS; Yacubian EM
Epilepsy Behav; 2006 May; 8(3):606-9. PubMed ID: 16504593
[TBL] [Abstract][Full Text] [Related]
7. Sleep disturbances in juvenile myoclonic epilepsy: a sleep questionnaire-based study.
Krishnan P; Sinha S; Taly AB; Ramachandraiah CT; Rao S; Satishchandra P
Epilepsy Behav; 2012 Mar; 23(3):305-9. PubMed ID: 22366052
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
Gürer R; Aydın Ş; Özkara Ç
Seizure; 2019 Aug; 70():43-48. PubMed ID: 31252363
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
[TBL] [Abstract][Full Text] [Related]
10. [Juvenile myoclonic epilepsy].
Ercegovac MD; Vojvodić N; SokićDV ; Janković SM; Drulović J; Stojsavljević N; Lević Z
Srp Arh Celok Lek; 1998; 126(9-10):335-44. PubMed ID: 9863404
[TBL] [Abstract][Full Text] [Related]
11. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.
Bodenstein-Sachar H; Gandelman-Marton R; Ben-Zeev B; Chapman J; Blatt I
Acta Neurol Scand; 2011 Jul; 124(1):22-7. PubMed ID: 21208196
[TBL] [Abstract][Full Text] [Related]
12. Altered polysomnographic profile in juvenile myoclonic epilepsy.
Krishnan P; Sinha S; Taly AB; Ramachandraiah CT; Rao S; Satishchandra P
Epilepsy Res; 2014 Mar; 108(3):459-67. PubMed ID: 24462228
[TBL] [Abstract][Full Text] [Related]
13. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
[TBL] [Abstract][Full Text] [Related]
14. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
15. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
Asadi-Pooya AA; Hashemzehi Z; Emami M
Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam monotherapy in juvenile myoclonic epilepsy.
Sharpe DV; Patel AD; Abou-Khalil B; Fenichel GM
Seizure; 2008 Jan; 17(1):64-8. PubMed ID: 17692537
[TBL] [Abstract][Full Text] [Related]
17. Effect of valproate on the sleep microstructure of juvenile myoclonic epilepsy patients - a cross-sectional CAP based study.
Nayak CS; Sinha S; Nagappa M; Kandavel T; Taly AB
Sleep Med; 2016 Jan; 17():129-33. PubMed ID: 26847987
[TBL] [Abstract][Full Text] [Related]
18. Phenotyping juvenile myoclonic epilepsy. Praxis induction as a biomarker of unfavorable prognosis.
Uchida CG; de Carvalho KC; Guaranha MS; Guilhoto LM; de Araújo Filho GM; Wolf P; Yacubian EM
Seizure; 2015 Nov; 32():62-8. PubMed ID: 26552565
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
[TBL] [Abstract][Full Text] [Related]
20. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
